Chemours Company (The) ($CC) Stock Forecast: Up 5.0% Today

What is Chemours Company (The)?

The Chemours Company (CC) disclosed its fourth-quarter and full-year 2025 financial results, resulting in a notable decline in its stock price. Despite obstacles in the Advanced Performance Materials segment, the company has been actively pursuing strategies to fortify its market position.

Why is Chemours Company (The) going up?

CC stock is up 5.0% on Mar 9, 2026 18:10

• An inquiry triggered by a specific firm in response to the stock price drop may have rattled investors initially, yet subsequent market activity indicates a more positive investor sentiment.
• The increased institutional investments from Neo Ivy Capital Management and American Century Companies Inc. signal a growing belief in Chemours' long-term prospects, despite varied analyst evaluations and recent downward revisions in earnings forecasts.
• Chemours' adoption of Adobe Marketo Engage to enhance marketing outcomes demonstrates a commitment to expansion and customer interaction, potentially contributing to the recent positive market trends.
• While short-term hurdles may have affected Chemours' stock value, the company's strategic efforts and investor trust appear to be propelling the recent market upswing.

CC Price Chart

CC Technical Analysis

CC News

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against The Chemours Company (CC) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into The Chemours Company (NYSE:CC) following a significant drop in its stock price after the company reported its fourth-quarter and full-year 2025 financial results. The decline of 16.51% was attributed to a one-time inventory charge and "short-term cyclical end market headwinds" in its Advanced Performance Materials segment. The firm is encouraging investors who purchased Chemours securities to learn more about the investigation and potentially participate in class action claims.

https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1140759

Chemours Co. Opens Weak with 5.45% Gap Down Amid Market Concerns

The Chemours Co. experienced a 5.45% gap down today, despite a slight monthly gain, contrasting with a modest S&P 500 decline. The specialty chemicals company shows a negative return on equity and a high price-to-earnings ratio, though it maintains a stable dividend yield and manageable debt. Technical indicators generally suggest a bullish to mildly bullish trend for the stock.

https://www.marketsmojo.com/news/stocks-in-action/chemours-co-opens-weak-with-545-gap-down-amid-market-concerns-3870348

Neo Ivy Capital Management Buys Shares of 93,260 The Chemours Company $CC

Neo Ivy Capital Management acquired 93,260 shares of The Chemours Company (NYSE:CC) valued at approximately $1.48 million, making it a new institutional holder. Despite mixed analyst ratings and recent negative earnings forecast revisions, Chemours reported an EPS beat and announced a quarterly dividend. The company, a spin-off from E. I. du Pont de Nemours and Company, faces an investor investigation, which introduces legal risk.

https://www.marketbeat.com/instant-alerts/filing-neo-ivy-capital-management-buys-shares-of-93260-the-chemours-company-cc-2026-03-07/

American Century Companies Inc. Purchases 490,988 Shares of The Chemours Company $CC

American Century Companies Inc. significantly increased its stake in The Chemours Company (NYSE:CC) by 26% in Q3, acquiring 490,988 additional shares to own a total of 2,378,591 shares valued at $37.68 million. While institutional ownership stands at 76.26%, analysts have mixed ratings on Chemours, with a consensus "Hold" and an average price target of $18.40, though some firms recently raised their targets. Chemours also reported beating Q3 EPS estimates, recorded $1.33 billion in revenue, and declared a quarterly dividend of $0.0875.

https://www.marketbeat.com/instant-alerts/filing-american-century-companies-inc-purchases-490988-shares-of-the-chemours-company-cc-2026-03-07/

Chemours increases MQLs with Adobe Marketo Engage | Adobe Australia

Chemours, a specialty chemical company, significantly increased its marketing qualified leads (MQLs) and conversion rates by implementing Adobe Marketo Engage. This enabled the company to send over 1,000 qualified leads directly to its sales team, improve engagement with various customer segments through personalized messaging, and optimize its marketing budget. The platform streamlined lead qualification, scoring, and nurturing, making marketing efforts more measurable and efficient.

https://business.adobe.com/au/customer-success-stories/chemours-case-study.html

Trending Today

Wheat ($WHEAT) Commodity Forecast: Down 6.2% Today

Gasoline ($GASOLINE) Commodity Forecast: Down 13.3% Today

Silver ($XAG) Commodity Forecast: Up 8.2% Today

Bitcoin ($BTC) Crypto Forecast: Up 5.3% Today

ZCash ($ZEC) Crypto Forecast: Up 9.3% Today

Corn ($CORN) Commodity Forecast: Down 5.1% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.4% Today

Ethereum ($ETH) Crypto Forecast: Up 5.9% Today

Natural Gas ($GAS) Commodity Forecast: Down 9.0% Today

Brent Crude Oil ($BRENT) Commodity Forecast: Down 16.6% Today

Chemours Company (The) Price History

20.01.2026 - CC Stock was down 18.3%

• Chemours (CC) encountered a noticeable earnings shortfall in Q4, primarily due to decreasing sales and profitability in its Advanced Performance Materials sector.
• Despite seeing growth in data-center cooling markets, the disappointing earnings report caused a significant drop in Chemours' stock value.
• Although the company made strategic moves to expand in Thermal & Specialized Solutions and Advanced Performance Materials, the lackluster Q4 performance in the APM segment took the spotlight.
• Chemours' failure to meet earnings expectations and the subsequent decline in its stock price underscore the challenges in the APM division, prompting concerns about the company's financial condition and distress signals.

20.01.2026 - CC Stock was down 21.2%

• Chemours (CC) experienced a notable Q4 earnings shortfall, attributed to a decline in sales and profitability within its Advanced Performance Materials segment, resulting in a downturn in the market.
• Despite an uptick in data-center cooling markets, disappointing Q4 performance and earnings contributed to a substantial drop in Chemours' stock value.
• The company's failure to meet estimated Q4 adjusted EPS as per FactSet and the announcement of reduced earnings and sales intensified bearish sentiments.
• Going forward, Chemours projects revenue growth in 2026 driven by Opteon™ Refrigerants demand and cost-saving initiatives, potentially reversing the current downward trajectory of the stock.

20.01.2026 - CC Stock was down 14.3%

• CC reported Q4 earnings that fell short of analyst estimates, with adjusted EPS at $0.05 compared to the expected $0.07, and revenue of $1.3 billion missing the estimated $1.33 billion.
• Despite the earnings miss, the stock experienced significant growth in the last three months, up 84.71%, and 16.76% in the last twelve months, indicating positive investor sentiment prior to the recent earnings report.
• The company attributed the net loss in Q4 and full year to lower cost absorption, non-cash inventory charges, and litigation-related expenses, impacting its financial performance.
• Chemours Co. anticipates future growth in net sales and adjusted EBITDA for 2026, driven by Opteon™ Refrigerants demand and strategic cost reductions, providing a positive outlook despite the current earnings disappointment.

23.01.2026 - CC Stock was up 5.2%

• The stock of Chemours (CC) experienced a strong bullish movement today.
• Positive adjustments to price targets and ratings likely boosted investor confidence in the company's future prospects.
• Despite facing challenges such as disappointing Q4 earnings and ongoing litigation, Chemours' focus on implementing pricing actions and divesting assets to strengthen its financial position seems to have resonated positively with investors.
• The company's projected consolidated net sales growth for 2026 and improved adjusted EBITDA and free cash flow outlook might have contributed to the bullish sentiment surrounding the stock today.

04.02.2026 - CC Stock was up 5.1%

• The upward movement in CC's stock may be attributed to the favorable quarterly EPS results and outperforming expectations despite a decrease in revenue compared to the previous year.
• Actions like equity grants and share withholdings for tax obligations by Chemours executives may have boosted investor confidence in the company's future outlook.
• Following a stock price decline after the financial results, ongoing investigations by a legal firm might have initially caused market uncertainty, but positive performance indicators helped restore investor faith and drive the bullish movement.
• Despite Quantbot Technologies LP reducing its stake in Chemours, the company's dividend announcement and overall financial health likely reassured investors, contributing to the upward trajectory.

03.02.2026 - CC Stock was down 7.9%

• Stake reductions by Quantbot Technologies LP and Vanguard Group Inc. indicate a lack of confidence in the company.
• Negative sentiment is heightened by an ongoing investigation into the company following a stock price drop linked to one-time inventory charges and market challenges.
• Despite surpassing quarterly EPS estimates and achieving a positive return on equity, a year-over-year revenue decline may have contributed to the stock's bearish performance.
• The bullish outlook from FelixQE's Substack, emphasizing the company's undervaluation and growth potential amidst PFAS litigation, stands in contrast to prevailing market sentiment, indicating a divergence in investor perspectives.

24.01.2026 - CC Stock was up 5.0%

• Chemours Co reported a net loss mainly attributed to litigation-related charges and increased costs, impacting its financial performance negatively in its annual Form 10-K report.
• Despite the loss, Chemours is working on strengthening its ties with the semiconductor industry, increasing adoption of its Opteon refrigerants, and streamlining its portfolio through asset sales for debt reduction.
• The company is encountering operational challenges and legal issues, including a lawsuit regarding PFAS contamination. This situation might have influenced the negative market sentiment, although there is anticipated support from its Opteon product line as Jefferies raised its stock price target.

05.02.2026 - CC Stock was down 5.4%

• Analysts have raised their price targets for Chemours, showing optimism and positive expectations for the stock.
• An investigation into potential claims against Chemours following a stock price decrease due to a one-time inventory charge may have impacted the bearish movement.
• Reports of an executive receiving restricted stock units (RSUs) and shares being held for tax purposes might have also influenced investor sentiment.
• The contrasting information of price target increases and investigations into financial disclosures likely caused uncertainty and contributed to the downward trend in Chemours' market performance today.

27.01.2026 - CC Stock was up 5.5%

• Chemours (CC) experienced a bullish trend today due to investor focus on the company's new AI cooling partnership and analyst updates.
• The successful private offering of $700 million in senior notes due 2034 also contributed to the positive market movement.
• Despite concerns raised by a law firm regarding potential securities fraud and market headwinds, the company's undervaluation according to discounted cash flow models and price-to-sales ratios has helped reassure investors.
• The company's valuation and recent financial results have inspired volatility, but the overall market sentiment remains optimistic about Chemours' future prospects.

26.01.2026 - CC Stock was down 5.4%

• The bearish movement in Chemours (CC) stock today could be attributed to profit-taking by investors after a period of undervaluation.
• The increase in price targets by financial institutions may have initially boosted confidence in the stock, but the market sentiment might have shifted due to concerns about the company's negative net margin and P/E ratio.
• The joint development agreement with 2CRSi for advanced cooling solutions could be a positive long-term catalyst for Chemours, but short-term market dynamics might have overshadowed this news.
• Overall, the bearish movement in CC's stock today seems to reflect a mix of valuation concerns, profit-taking, and short-term market sentiment, despite promising developments in its technology partnerships.

10.01.2026 - CC Stock was up 5.2%

• The stock hit a 52-week high due to strong investor confidence and significant gains over the past six months, despite operating with substantial debt.
• Analysts predict profitability this year, with an EPS of $0.91, reflecting positive sentiment towards the company's financial performance.
• The increased stake by the New York State Common Retirement Fund by over 1,000% in Q3 also contributed to the bullish movement, indicating growing institutional interest in Chemours.
• The announcement of the upcoming fourth-quarter earnings release and conference call may have further boosted investor optimism, providing a catalyst for the stock's upward momentum.

09.02.2026 - CC Stock was up 5.0%

• An inquiry triggered by a specific firm in response to the stock price drop may have rattled investors initially, yet subsequent market activity indicates a more positive investor sentiment.
• The increased institutional investments from Neo Ivy Capital Management and American Century Companies Inc. signal a growing belief in Chemours' long-term prospects, despite varied analyst evaluations and recent downward revisions in earnings forecasts.
• Chemours' adoption of Adobe Marketo Engage to enhance marketing outcomes demonstrates a commitment to expansion and customer interaction, potentially contributing to the recent positive market trends.
• While short-term hurdles may have affected Chemours' stock value, the company's strategic efforts and investor trust appear to be propelling the recent market upswing.